The RealReal

Congrats to The RealReal on their IPO. Bell ringing has never looked so stylish.

More

Experience

A fine
balance

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Team

Greater perspectives create greater outcomes.

Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top—all with a unique style and a healthy dose of humor.

Companies

A dynamic
portfolio

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Companeis

The future looks bright.

Say hello to our extended family. An impressive roster of agile and imaginative companies that are building the future of healthcare and technology, one big idea at a time. Our portfolio of entrepreneurial muscle includes 59 IPOs and 134 M&As. And counting.

Approach

A hand
in every stage

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach

About

This is Canaan.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.

The RealReal

>The RealReal

Congrats to The RealReal on their IPO. Bell ringing has never looked so stylish.

More

Experience

A fine
balance

>Berkshire Grey

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Companies

A dynamic
portfolio

>IDEAYA Biosciences

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Approach

A hand
in every stage

>Turo

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach
Highlight

MedCityNews: Pact Pharma enrolls first patients in Phase Ia/Ib solid tumor cell therapy study

PACT has started dosing patients in an early-stage clinical trial of a product candidate designed to be targeted to proteins in cancer cells unique...
Highlight

FierceBiotech: A personalized CAR-T to attack every solid tumor? PACT Pharma has a plan

PACT Pharma is developing a method for taking T cells from patients with solid tumors and engineering them to be able to recognize and attack those...
Highlight

Forbes: Why the founder Of Kin Euphorics wants us to replace booze with bliss

While cultivating social connection is a fundamental human need, Jen Batchelor wanted to create a solution for experiencing more moments of revelry...
Highlight

The Wall Street Journal: IAC to invest $250M in car-sharing app Turo

IAC chief estimates car-sharing marketplace could be at least as big as car-rental business.